The article discusses the development of a treatment for sickle-cell disease through genetic engineering and editing of genes. The author reflects on genetic mutations in children that prevent the development of sickle-cell anemia. Emphasis is given to topics such as the connection between survival of malaria and inherited hemoglobin disorders as studied by scientist J. B. S. Haldane, the production of fetal hemoglobin, and the development of a drug to prevent mutated hemoglobin from combining.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados